Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
AMAG Pharmaceuticals, Inc. (NQ: AMAG)
20.81 USD  +0.08 (+0.39%)
Streaming Delayed Price  /  Updated: 3:27 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about AMAG Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 Next >
AMAG Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2012
July 26, 2012
from Business Wire News Releases
Collegium Pharmaceutical Announces the Appointment of Gino Santini to Board of Directors
July 24, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call on July 26, 2012 at 8:00 a.m. ET to Discuss Financial Results for the Quarter Ended June 30, 2012
July 19, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Announces Positive Preliminary Results from its Phase III Study Evaluating Feraheme Compared to Placebo in Patients with Iron Deficiency Anemia
July 18, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Realigns Operating Cost Structure to Focus on Continued Feraheme Growth and Business Development Activities
June 25, 2012
from Business Wire News Releases
Rienso® (Ferumoxytol) Receives European Marketing Authorization for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
June 22, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
May 29, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Appoints William Heiden as President and Chief Executive Officer
May 09, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Announces First Quarter 2012 Financial Results
May 01, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call on May 1, 2012 at 4:30 p.m. ET to Discuss Financial Results for the Quarter Ended March 31, 2012
April 24, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
April 20, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Announces Preliminary Results from its Phase III Study Evaluating Feraheme Compared to IV Iron Sucrose in Patients with Iron Deficiency Anemia
March 07, 2012
from Business Wire News Releases
CORRECTING and REPLACING AMAG Pharmaceuticals, Inc. to Host Conference Call on March 7, 2012 at 4:30 p.m. ET to Discuss Feraheme Clinical Trial Results
March 06, 2012
from Business Wire News Releases
AMAG Announces Fourth Quarter and Year End 2011 Financial Results
March 05, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 24th Annual ROTH Conference
March 02, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Host Conference Call on March 5, 2012 at 4:30 p.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2011
February 23, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
February 13, 2012
from Business Wire News Releases
A Forward Look, The Year Ahead - Featured Research on AMAG Pharmaceuticals, Inc. and Akorn, Inc.
February 10, 2012
from Marketwired News Releases
AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board
February 07, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader Iron Deficiency Anemia Indication
January 30, 2012
from Business Wire News Releases
AMAG Pharmaceuticals Provides Business Update
January 09, 2012
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference
January 04, 2012
from Business Wire News Releases
Health Canada Approves Feraheme® (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease
December 12, 2011
from Business Wire News Releases
AMAG Pharmaceuticals Announces Preliminary Data Regarding the Safety and Efficacy of a Single Infusion of 1020 mg Ferumoxytol (Feraheme®) in Patients with Iron Deficiency Anemia
December 12, 2011
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference
November 22, 2011
from Business Wire News Releases
AMAG Pharmaceuticals Hires Financial Advisor as the Company Explores All Opportunities to Enhance Stockholder Value
November 17, 2011
from Business Wire News Releases
AMAG Pharmaceuticals, Inc. Announces Positive Data from the FIRST Trial, A Head-to-Head Comparison Trial of Ferumoxytol (Feraheme®) Compared to Iron Sucrose
November 12, 2011
from Business Wire News Releases
Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on AMAG Pharmaceuticals, Inc. and Hologic, Inc.
November 07, 2011
from Marketwired News Releases
AMAG Announces Financial Results for the Third Quarter Ended September 30, 2011
November 04, 2011
from Business Wire News Releases
AMAG Pharmaceuticals Reschedules Third Quarter Financial Results Conference Call to November 4, 2011 at 8:00 a.m. ET
November 03, 2011
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here